We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+13.68%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$7.47B
AUM Growth
+$318M
Cap. Flow
-$240M
Cap. Flow %
-3.22%
Top 10 Hldgs %
15.62%
Holding
988
New
245
Increased
155
Reduced
180
Closed
244

Top Buys

Rank Stock Value
1
TEL icon
TE Connectivity
TEL
+$145M
2
BKNG icon
Booking.com
BKNG
+$116M
3
EA icon
Electronic Arts
EA
+$87.6M
4
TMO icon
Thermo Fisher Scientific
TMO
+$74.1M
5
MSFT icon
Microsoft
MSFT
+$66.5M

Sector Composition

Rank Sector Weight
1 Healthcare 33.33%
2 Technology 31.02%
3 Industrials 9.63%
4 Financials 6.43%
5 Consumer Discretionary 5.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALTI icon
251
AlTi Global
ALTI
$512M
$7.54M 0.1%
749,999
AGAC
252
DELISTED
African Gold Acquisition Corp
AGAC
$7.54M 0.1%
750,000
+300,000
+67% +$2.99M
EPAM icon
253
EPAM Systems
EPAM
$5.74B
$7.46M 0.1%
22,755
-53,020
-70% -$18M
BBY icon
254
Best Buy
BBY
$17.8B
$7.45M 0.1%
92,910
+36,868
+66% +$2.71M
PRTA icon
255
Prothena Corp
PRTA
$444M
$7.45M 0.1%
+123,623
New +$7.24M
TXG icon
256
10x Genomics
TXG
$6.08B
$7.44M 0.1%
+204,054
New +$6.67M
EVH icon
257
Evolent Health
EVH
$346M
$7.42M 0.1%
264,328
-200,433
-43% -$5.75M
VOR icon
258
Vor Biopharma
VOR
$1.21B
$7.39M 0.1%
55,556
HWM icon
259
Howmet Aerospace
HWM
$117B
$7.34M 0.1%
186,320
-203,971
-52% -$7.43M
LGAC
260
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
$7.32M 0.1%
724,550
+12,100
+2% +$121K
VERV
261
DELISTED
Verve Therapeutics
VERV
$7.28M 0.1%
376,277
+1,282
+0.3% +$34K
CHAA
262
DELISTED
Catcha Investment Corp
CHAA
$7.18M 0.1%
711,400
+40,400
+6% +$404K
GDRX icon
263
GoodRx Holdings
GDRX
$1.11B
$7.09M 0.09%
+1,521,212
New +$7.49M
MELI icon
264
Mercado Libre
MELI
$97.5B
$7.06M 0.09%
8,347
-5,965
-42% -$5.31M
AGGRW
265
DELISTED
Agile Growth Corp Warrant
AGGRW
$7.06M 0.09%
67,389
MIRM icon
266
Mirum Pharmaceuticals
MIRM
$6.45B
$7.03M 0.09%
360,592
+3,640
+1% +$72K
LEGN icon
267
Legend Biotech
LEGN
$3.69B
$6.94M 0.09%
138,967
+7,467
+6% +$362K
FISV
268
Fiserv Inc
FISV
$28.9B
$6.86M 0.09%
+67,889
New +$6.76M
FORG
269
DELISTED
ForgeRock, Inc.
FORG
$6.81M 0.09%
+298,894
New +$6.51M
MDRX
270
DELISTED
Veradigm Inc. Common Stock
MDRX
$6.7M 0.09%
380,036
-51,771
-12% -$867K
JANX icon
271
Janux Therapeutics
JANX
$976M
$6.66M 0.09%
505,364
+105,183
+26% +$1.54M
VRNA
272
DELISTED
Verona Pharma
VRNA
$6.53M 0.09%
250,000
-125,033
-33% -$1.66M
FRXB
273
DELISTED
Forest Road Acquisition Corp. II
FRXB
$6.52M 0.09%
650,000
LUNG icon
274
Pulmonx
LUNG
$85M
$6.46M 0.09%
765,798
+217,286
+40% +$2.07M
TENB icon
275
Tenable Holdings
TENB
$3.97B
$6.45M 0.09%
169,043
+83,393
+97% +$3.06M

Similar funds

Woodline Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Woodline Partners held 988 positions worth $7.47B, up 4.4% from $7.16B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners withdrew a net $240M in Q4 2022, closing 244 positions and reducing 180 holdings. Its most notable exit was Amazon, an estimated $77.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 36% a quarter earlier, followed by Technology and Industrials.

Against the trend, Woodline Partners opened a new position in Booking.com worth $123M.

  • Woodline Partners's largest Q4 2022 buy was Booking.com: 1,526,600 shares worth $123M.
  • Woodline Partners added most to TE Connectivity in Q4 2022, an estimated $145M increase.
  • Woodline Partners's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $169M.
  • Woodline Partners fully exited Amazon in Q4 2022, selling an estimated $77.2M.
  • Woodline Partners's ten largest holdings make up 16% of its $7.47B portfolio in Q4 2022.
  • Woodline Partners opened 245 new positions and closed 244 in Q4 2022.
  • Woodline Partners's portfolio value rose 4.4% quarter-over-quarter to $7.47B.

Based on Woodline Partners's 13F filing for Q4 2022, filed 14 Feb 2023.